Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pacira Pharm Inc (PCRX)

Pacira Pharm Inc (PCRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,736,671
  • Shares Outstanding, K 45,437
  • Annual Sales, $ 541,530 K
  • Annual Income, $ 41,980 K
  • 60-Month Beta 0.88
  • Price/Sales 5.09
  • Price/Cash Flow 17.82
  • Price/Book 4.04
Trade PCRX with:

Options Overview Details

View History
  • Implied Volatility 50.26% ( -1.30%)
  • Historical Volatility 41.54%
  • IV Percentile 81%
  • IV Rank 68.54%
  • IV High 60.07% on 08/17/21
  • IV Low 28.88% on 06/02/21
  • Put/Call Vol Ratio 0.22
  • Today's Volume 11
  • Volume Avg (30-Day) 20
  • Put/Call OI Ratio 2.74
  • Today's Open Interest 2,645
  • Open Int (30-Day) 3,800

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.67
  • Number of Estimates 5
  • High Estimate 0.80
  • Low Estimate 0.54
  • Prior Year 0.60
  • Growth Rate Est. (year over year) +11.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.74 +2.54%
on 05/12/22
76.94 -21.72%
on 04/26/22
-16.15 (-21.14%)
since 04/25/22
3-Month
58.74 +2.54%
on 05/12/22
82.16 -26.69%
on 04/08/22
-6.90 (-10.28%)
since 02/25/22
52-Week
45.05 +33.70%
on 10/11/21
82.16 -26.69%
on 04/08/22
-6.17 (-9.29%)
since 05/25/21

Most Recent Stories

More News
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

PCRX : 60.23 (-0.69%)
Pacira's (PCRX) Q1 Earnings Miss Estimates, Revenues Rise Y/Y

Pacira's (PCRX) earnings fall shy of estimates in the first quarter of 2022 while revenues beat the same.

PCRX : 60.23 (-0.69%)
XNCR : 22.23 (-0.98%)
CRBP : 0.3024 (-2.70%)
SLNO : 0.1699 (-8.16%)
Pacira (PCRX) Q1 Earnings Miss Estimates

Pacira (PCRX) delivered earnings and revenue surprises of -13.51% and 0.32%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

PCRX : 60.23 (-0.69%)
MEIP : 0.4171 (-1.84%)
Pacira BioSciences Reports First Quarter 2022 Financial Results

-- First quarter revenue of $158 million, up 33% over prior year ---- Strong topline performance delivers net income and significantly positive adjusted...

PCRX : 60.23 (-0.69%)
Why Pacira (PCRX) Could Beat Earnings Estimates Again

Pacira (PCRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

PCRX : 60.23 (-0.69%)
3 Small-Cap Medical Stocks With Big Momentum

Now is a good time to take a closer look at these stocks.

RGNX : 19.45 (+0.52%)
CORT : 19.94 (-0.30%)
PCRX : 60.23 (-0.69%)
Pacira (PCRX) to Report Q1 Results: Wall Street Expects Earnings Growth

Pacira (PCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PCRX : 60.23 (-0.69%)
What to Expect From Centene (CNC) this Earnings Season?

Centene's (CNC) first-quarter results are likely to reflect growing revenues attributable to a rise in premiums and membership, partly offset by lower investment income.

VRTX : 270.84 (+0.88%)
CNC : 85.31 (-2.18%)
PCRX : 60.23 (-0.69%)
PRPH : 8.88 (+6.35%)
Here's Why Pacira (PCRX) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

PCRX : 60.23 (-0.69%)
Pacira BioSciences to Participate in Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference

TAMPA, Fla., April 05, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led...

PCRX : 60.23 (-0.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers. These products are developed using the company's proprietary DepoFoam drug...

See More

Key Turning Points

3rd Resistance Point 62.94
2nd Resistance Point 62.15
1st Resistance Point 61.19
Last Price 60.23
1st Support Level 59.44
2nd Support Level 58.65
3rd Support Level 57.69

See More

52-Week High 82.16
Fibonacci 61.8% 67.98
Fibonacci 50% 63.61
Last Price 60.23
Fibonacci 38.2% 59.23
52-Week Low 45.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar